Evaluation of clofazimine in vitiligo.
20 patients with vitiligo were treated with 100 mg of clofazimine daily. Half of these cases were exposed to sunlight and the remaining cases were given no sun exposure. After 3 months of therapy, repigmentation of lesions was seen in 2 cases only, 1 in each group. Sun exposure had no beneficial effect.
D000293:Adolescent; D000328:Adult; D002991:Clofazimine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D013472:Sunlight; D014820:Vitiligo / Q000188:drug therapy*
D002991:Clofazimine